Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HXTL vs Celecoxib for Non-specific Low Back Pain
NCT06336993Phase 4Completed
- Sponsor
- Tongde Hospital of Zhejiang Province
- Start
- Jan 2022
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Huaxintonglin in non-specific low back pain (NSLBP), sponsored by Tongde Hospital of Zhejiang Province. Started Jan 2022; status: completed.
02
Drugs
Huaxintonglin
03
Conditions
non-specific low back pain (NSLBP)
Beyond the preview
Go deeper on NCT06336993.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06336993.